We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Jackson ImmunoResearch Anti-Human IgE Antibodies

Jackson ImmunoResearch Anti-Human IgE Antibodies content piece image

Want a FREE PDF version of this product news?

Complete the form below and we will email you a PDF version of "Jackson ImmunoResearch Anti-Human IgE Antibodies"

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.
Read time:
 

Jackson ImmunoResearch announces a new addition to its range of products for scientists developing immunoassays for the serology and diagnostics markets.


JIR Mouse Monoclonal Anti-Human IgE antibodies are the latest addition to our suite of products suitable for diagnostics research and development. Specific for Human IgE antibodies, they complement our existing Anti-Human IgG, IgM, and IgA antibodies. Anti-Human IgE is available conjugated to a select range of reporter molecules, including Alkaline Phosphatase and Biotin enabling excellent sensitivity for immunoassay applications.


Jackson ImmunoResearch Anti-Human IgE is a mouse-derived monoclonal antibody with reactivity to human E class immunoglobulins and is epsilon (ε) chain specific and has been tested by ELISA and shows minimal cross-reactivity to other classes of human immunoglobulin (IgG, IgM, or IgA).


JIR Mouse Anti-Human IgE is available conjugated to a range of reporter molecules and is suitable to detect human IgE by a variety of techniques, including ELISA (Enzyme-linked Immunosorbent Assay), Lateral Flow Immunoassay (LFIA), Flow cytometry, Western blot, and CLIA (Chemiluminescent Immunoassay).
Matthew Smith, Commercial Director, commented, "We are excited to launch Jackson ImmunoResearch Anti-Human IgE antibodies as part of our existing suite of reagents suitable for developing high-quality human serology and diagnostic tests. They will allow scientists to harness the sensitivity and specificity of JIR antibodies in a wider range of fields such as allergy."
 

Advertisement